Clinical Trial Update: OPIE in the Thin Interventricular Septum [NA]

View source ↗

Summary

A clinical trial involving OPIE for hypertrophic cardiomyopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• OPIE

Snippet

Sponsor: NYU Langone Health | Conditions: Hypertrophic Cardiomyopathy | NA | Status: WITHDRAWN